|
Extramural Support
|
RMS2013 [E]
|
$366,054,072
|
$157,367
|
N/A
|
National Cancer Institute
|
|
Statistics and Data Center for the Alliance for Clinical Trials in Oncology
|
5U10CA180882-05
|
$8,303,242
|
|
MANDREKAR, SUMITHRA
|
MAYO CLINIC ROCHESTER
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-05
|
$8,073,787
|
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Adult Leukemia Research Center
|
2P01CA018029-42A1
|
$3,990,001
|
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Center for Research to Optimize Precision Lung Cancer Screening in Diverse Populations
|
1UM1CA221939-01
|
$3,139,491
|
|
RITZWOLLER, DEBRA
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
Evaluating How Tobacco Control Policies are Shaping the Nicotine Delivery Market
|
5P01CA200512-03
|
$2,893,402
|
|
CUMMINGS, KENNETH
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Research on Prostate Cancer in Men of African Ancestry: Defining the Roles of Genetics, Immunity and Stress (RESPOND)
|
1U19CA214253-01A1
|
$2,836,742
|
|
HAIMAN, CHRISTOPHER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Optimization of High Dose Conformal Therapy
|
5P01CA059827-20
|
$2,748,478
|
$329,817
|
TEN HAKEN, RANDALL
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Pediatric Brain Tumor Consortium (PBTC)
|
5UM1CA081457-20
|
$2,711,850
|
|
ONAR-THOMAS, ARZU
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
ASPiRE: Advancing Science & Practice in the Retail Environment
|
1P01CA225597-01
|
$2,575,060
|
|
RIBISL, KURT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
SPORE in Breast Cancer
|
2P50CA058223-24A1
|
$2,499,932
|
|
PEROU, CHARLES
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Life Course Cancer Epidemiology Cohort in Women
|
2U01CA176726-06
|
$2,423,825
|
|
WILLETT, WALTER
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
Integration of Clinical and Molecular Biomarkers for Melanoma Survival
|
5P01CA206980-02
|
$2,361,160
|
|
BERWICK, MARIANNE
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Mayo Clinic Hepatobiliary SPORE
|
1P50CA210964-01A1
|
$2,300,000
|
|
MC NIVEN, MARK
|
MAYO CLINIC ROCHESTER
|
|
Evolution and Treatment Response of Brain, Breast, and Hematologic Malignancies
|
5U54CA193461-04
|
$2,288,376
|
|
MICHOR, FRANZISKA
|
DANA-FARBER CANCER INST
|
|
SPORE in Soft Tissue Sarcoma
|
1P50CA217694-01A1
|
$2,286,505
|
|
SINGER, SAMUEL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Molecular Biology and Genetics of Human Tumor Viruses
|
2P01CA022443-41
|
$2,272,641
|
$136,358
|
LAMBERT, PAUL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
|
5U01CA195568-04
|
$2,246,690
|
|
CERHAN, JAMES
|
MAYO CLINIC ROCHESTER
|
|
Measuring, Modeling and Controlling Heterogeneity
|
5U54CA209988-02
|
$2,191,539
|
$854,700
|
GRAY, JOE
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Research Center for Cancer Systems Biology: Cancer Cell Map Initiative
|
5U54CA209891-02
|
$2,179,219
|
$196,130
|
KROGAN, NEVAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Experimental Therapy for Brain Tumors
|
1P01CA225622-01
|
$2,170,371
|
|
SAMPSON, JOHN
|
DUKE UNIVERSITY
|
|
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer
|
5U54CA193419-04
|
$2,095,133
|
|
O'HALLORAN, THOMAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Infrastructure for Pathways, a Prospective Study of Breast Cancer Survivorship
|
5U01CA195565-03
|
$2,012,287
|
|
KUSHI, LAWRENCE
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
DRUG DELIVERY SYSTEM TO SAVE HEARING DURING PEDIATRIC CHEMOTHERAPY REGIMENS. POP 8/30/2018 - 08/28/2020.
|
261201700023C
|
$1,999,787
|
$1,999,787
|
SHIMOJI PHD, MIKA
|
OTOMAGNETICS, LLC
|
|
Normal and Neoplastic Growth in the Brain
|
5P01CA096832-14
|
$1,999,508
|
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Detroit Research on Cancer Survivors (Detroit ROCS)
|
5U01CA199240-02
|
$1,995,543
|
|
SCHWARTZ, ANN
|
WAYNE STATE UNIVERSITY
|
|
Complexity, Cooperation and Community in Cancer
|
1U54CA217378-01A1
|
$1,986,971
|
|
LOWENGRUB, JOHN
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Liver Cancer: pre-Malignant Stiffening, Membrane Transduction, & Nuclear Rheology
|
5U54CA193417-04
|
$1,980,960
|
|
DISCHER, DENNIS
|
UNIVERSITY OF PENNSYLVANIA
|
|
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
|
ZIB BC 010906
|
$1,949,215
|
$1,949,215
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Arizona Cancer and Evolution Center (ACE)
|
1U54CA217376-01A1
|
$1,906,167
|
|
MALEY, CARLO
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Development of Novel Cancer Therapeutics by Targeting Sphingolipid Signaling
|
5P01CA203628-03
|
$1,836,914
|
|
OGRETMEN, BESIM
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
NK cells, their receptors, transplantation and cancer therapy
|
5P01CA111412-13
|
$1,814,553
|
|
MILLER, JEFFREY
|
UNIVERSITY OF MINNESOTA
|
|
Herpesviral Oncogenesis, Latency and Reactivation
|
5P01CA019014-39
|
$1,812,080
|
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Integrated EGFR function in cytokine-driven inflammation and cancer
|
5P01CA062220-23
|
$1,805,475
|
$180,548
|
STARK, GEORGE
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Pancreatic Cancer Detection Consortium
|
5U01CA210240-02
|
$1,783,224
|
|
HOLLINGSWORTH, MICHAEL
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
|
ZIA BC 008753
|
$1,671,202
|
$1,671,202
|
Pastan, Ira
|
CCR (NCI)
|
|
Pancreatic Cancer Metastasis
|
1P01CA217798-01A1
|
$1,643,391
|
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Genetic Modifiers of Initiation and Progression of Mammary Cancer
|
ZIA BC 011255
|
$1,639,741
|
|
Hunter, Kent
|
CCR (NCI)
|
|
Mechanisms of Esophageal Carcinogenesis
|
5P01CA098101-15
|
$1,607,533
|
|
RUSTGI, ANIL
|
UNIVERSITY OF PENNSYLVANIA
|
|
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
|
ZIA BC 008753
|
$1,606,820
|
$1,606,820
|
Pastan, Ira
|
CCR (NCI)
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
5U01CA200466-03
|
$1,563,388
|
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
IGF::OT::IGF
|
261201800038C
|
$1,499,993
|
|
-, -
|
INTELLIGENT AUTOMATION, INC.
|
|
IGF::OT::IGF
|
261201800047C
|
$1,499,914
|
|
-, -
|
CHARLES RIVER ANALYTICS, INC.
|
|
SmartStop: Programmable Transdermal Nicotine Replacement Therapy
|
4R44CA171786-02
|
$1,463,029
|
$1,463,029
|
Chang, Kuowei
|
CHRONO THERAPEUTICS, INC.
|
|
Molecular Determinants of Cancer Therapeutic Response
|
5P01CA077852-19
|
$1,458,213
|
$218,732
|
MONNAT, RAYMOND
|
UNIVERSITY OF WASHINGTON
|
|
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
|
ZIB BC 010906
|
$1,388,882
|
$1,388,882
|
Waldmann, Thomas
|
CCR (NCI)
|
|
H. pylori-Induced Inflammation and gastric cancer
|
5P01CA116087-11
|
$1,384,046
|
|
PEEK, RICHARD
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Intraoperative Near-Infrared Fluorescence Imaging
|
5R01CA115296-09
|
$1,362,767
|
$1,362,767
|
Frangioni, John
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Growth Factor Imaging
|
ZIA BC 010656
|
$1,320,390
|
$396,117
|
Choyke, Peter
|
CCR (NCI)
|
|
Extracellular Vesicles (EVs) and Genes in the Biology and Therapy of Gliomas
|
5P01CA069246-21
|
$1,316,832
|
|
BREAKEFIELD, XANDRA
|
MASSACHUSETTS GENERAL HOSPITAL
|
Total relevant funding to Bioengineering for this search: $185,779,743
|